… clinical profile of patients initiating evolocumab in real-world clinical practice, specifically
hospital cardiology … evolocumab in 31 Spanish hospital cardiology units from February-2016 to …

… In conclusion, the RETOSS-CARDIO study is the first national registry of patients treated with
evolocumab in hospital cardiology units in Spain, with a large and representative sample of …

… This study in the context of habitual clinical practice confirms the hypolipemiant … clinical
experience with evolocumab in Spain, such as the twin study of this one, the RETOSS-CARDIO …

… Cardiovascular disease is the primary cause of morbidity and mortality in patients with chronic
… This study was conducted to describe clinical characteristics, reasons for therapy initiation …

… Uno de los principales retos para nuestras sociedades científicas es justamente generar
nuestras propias guías, basadas en evidencia actualizada, luego difundirlas y aplicarlas para …

… Similar studies have been performed in Spain on evolocumab in clinical practice in
cardiology units and in lipid/internal medicine units31, 32. The results are comparable with those …

… cardioverter-defibrillators (ICD) and cardiac resynchronization therapy (CRT) improved …
clinical practice have been demonstrated, even in specialized settings (5–9). Although clinical …

… cardiovascular desarrollan guías de prevención, cuyo objetivo es la reducción del impacto
de la enfermedad cardiovascular … cardiovascular disease prevention in clinical practice. Eur J …

… clínicos basados en registros en cardiología: oportunidades y retos … clinical treatments
thanks to its low selection bias and unknown confounders. However, good clinical practice guide…

Cardiovascular surgery has an uncertain future ahead. There is a major concern with regards
to this in the US and Europe. This feeling of uncertainty is even stronger in Spain due to …